Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity
about
Expression of SCC-S2, an antiapoptotic molecule, correlates with enhanced proliferation and tumorigenicity of MDA-MB 435 cellsStimulation of CD30 in anaplastic large cell lymphoma leads to production of nuclear factor-kappaB p52, which is associated with hyperphosphorylated Bcl-3Inflammatory cytokines induce production of CHI3L1 by articular chondrocytesIdentification of a human NF-kappaB-activating protein, TAB3A case of nodular sclerosis Hodgkin's lymphoma repeatedly relapsing in the context of composite plasma cell-hyaline vascular Castleman's disease: successful response to rituximab and radiotherapyDengue virus infection induces interferon-lambda1 to facilitate cell migrationThe cnidarian origin of the proto-oncogenes NF-κB/STAT and WNT-like oncogenic pathway drives the ctenophores (Review)Role of immune escape mechanisms in Hodgkin's lymphoma development and progression: a whole new world with therapeutic implicationsHow Rheumatoid Arthritis Can Result from Provocation of the Immune System by Microorganisms and VirusesIdentification of Naf1/ABIN-1 among TNF-alpha-induced expressed genes in human synoviocytes using oligonucleotide microarraysNF-kappaB: a multifaceted transcription factor regulated at several levelsVBP15, a glucocorticoid analogue, is effective at reducing allergic lung inflammation in miceTNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma.Dimethylarginine dimethylaminohydrolase II overexpression attenuates LPS-mediated lung leak in acute lung injury.Analysis of normal-tumour tissue interaction in tumours: prediction of prostate cancer features from the molecular profile of adjacent normal cells.NF-κB affects proliferation and invasiveness of breast cancer cells by regulating CD44 expression.Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma.Coordinated binding of NF-kappaB family members in the response of human cells to lipopolysaccharide.Human β-defensin 3 promotes NF-κB-mediated CCR7 expression and anti-apoptotic signals in squamous cell carcinoma of the head and neck.EBV in Hodgkin Lymphoma.The molecular pathogenesis of Hodgkin lymphoma.Control of the inflammatory response mechanisms mediated by natural and induced regulatory T-cells in HCV-, HTLV-1-, and EBV-associated cancers.G-protein coupled receptor kinase 5 mediates lipopolysaccharide-induced NFκB activation in primary macrophages and modulates inflammation in vivo in mice.Heat-shock protein 90 alpha (HSP90α) modulates signaling pathways towards tolerance of oxidative stress and enhanced survival of hepatocytes of Mugil cephalus.Nuclear factor-kappaB (NF-kappaB) p65 interacts with Stat5b in growth plate chondrocytes and mediates the effects of growth hormone on chondrogenesis and on the expression of insulin-like growth factor-1 and bone morphogenetic protein-2The IkappaB kinase complex and NF-kappaB act as master regulators of lipopolysaccharide-induced gene expression and control subordinate activation of AP-1.EGCG inhibits proliferation, invasiveness and tumor growth by up-regulation of adhesion molecules, suppression of gelatinases activity, and induction of apoptosis in nasopharyngeal carcinoma cells.MicroRNA-7 Promotes Glycolysis to Protect against 1-Methyl-4-phenylpyridinium-induced Cell Death.JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis.Chemokine receptor 7 (CCR7) gene expression is regulated by NF-κB and activator protein 1 (AP1) in metastatic squamous cell carcinoma of head and neck (SCCHN).The homeoprotein DLX4 stimulates NF-κB activation and CD44-mediated tumor-mesothelial cell interactions in ovarian cancer.Absence of DAB2IP promotes cancer stem cell like signatures and indicates poor survival outcome in colorectal cancerNF-κB transcriptional activation by TNFα requires phospholipase C, extracellular signal-regulated kinase 2 and poly(ADP-ribose) polymerase-1c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis.Recurrent somatic loss of TNFRSF14 in classical Hodgkin lymphoma.IL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesisAugmented efficacy of brentuximab vedotin combined with ruxolitinib and/or Navitoclax in a murine model of human Hodgkin's lymphomaA roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma.Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma.
P2860
Q24304993-BF281181-4D41-4C52-B88F-861CD98A0B0AQ24316194-652A6CB8-72A3-437C-99FA-9A795C041268Q24338555-D0AB54CE-CB6C-48B9-8152-6FBC839A99E4Q24621651-36670A41-214C-40A8-9B8B-DB0EB8AE5C66Q24670564-8ADD669A-387F-4FE5-898E-C8CB20B6488EQ26700107-EA7DE5F7-690D-4444-A511-A99286B0FC14Q26799398-EFFA9F59-692B-43D4-8D97-75AB702122FBQ27011510-BEFCED6A-F760-4C5E-ADB4-BE01A4B35E5BQ27468876-716E6348-850F-46FC-8AD1-334ABE9EDEA3Q28205951-C8CE9A82-8339-4145-905A-CF1FEEE32E97Q28285466-518A054A-8991-4E71-8B20-6836A64B2AF8Q28487685-AF3B2E07-EC38-4E94-86E3-6908A1750731Q33432504-2CD02B34-40F2-4274-B678-7F838040A596Q33799650-8505B333-DAAB-4198-A6BB-4AD3EB495389Q33867402-A915E5B9-A0C9-44EB-9DF1-245293D76051Q34129082-1340FD4F-E2DA-428F-9819-22A5263CA881Q34480682-C6840E5A-7ED7-4FCE-9035-53460C428D7CQ34509419-87F10276-1B84-4724-828C-D905AD33D536Q34520408-C063F300-D2C7-4108-967F-E007AD1F9F76Q34549468-1B5BD6D2-B6A8-41D3-9E51-3C7711EB75D3Q34626576-34860375-AAB7-4D53-AB35-081347C7DDA5Q34708248-80609C8B-E60C-4D86-844F-C0E05A7A1888Q34721325-37E1CD1C-365D-45CD-9D64-2AAD3C2E3D8CQ35056222-EC4BDBAC-3E84-4755-80AD-3E2FE13E76FCQ35107411-9A0CA61A-B34C-4A7F-AE5C-15113E2D0F8BQ35126481-1E60A4E5-895C-4282-A138-7652D37E7F4BQ35138905-6D839E86-5141-4E4B-9311-56A3C356D00FQ35583229-08DA46B7-3F2D-4682-96F6-150E56491471Q35635353-1E0FA5D2-4246-410B-8570-FEF3A55315EEQ35728558-882140DF-D217-4B04-9B08-40E6E0521B6DQ35931850-4048ADC9-E9B7-403D-8543-7A98169CFC8AQ36275433-D6B42F74-1CFD-4A5B-849B-85191E75A9C7Q36348582-8293635F-6526-4E01-B5D7-AAA1A07FB614Q36399443-081228A2-3EA9-43B1-8B42-8B28313432A2Q36463861-8D14DF45-837C-4A08-9D09-D7DE30F854FAQ36591359-1A3E309B-65BD-4C7A-A2CA-C934C8082F3CQ36598782-C3BE5EA9-FFBB-42C4-B5F2-BFA660CFCC24Q36694809-57C28230-6F0B-4428-85BE-E82C99BEEBC7Q37016499-81AA0A72-A44A-4FCF-A941-7D91F74F79D2Q37326210-C182B0A2-5AE0-4ACB-9F26-8F449FED8D02
P2860
Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Nuclear factor kappaB-dependen ...... r of transcription 5a activity
@ast
Nuclear factor kappaB-dependen ...... r of transcription 5a activity
@en
Nuclear factor kappaB-dependen ...... r of transcription 5a activity
@nl
type
label
Nuclear factor kappaB-dependen ...... r of transcription 5a activity
@ast
Nuclear factor kappaB-dependen ...... r of transcription 5a activity
@en
Nuclear factor kappaB-dependen ...... r of transcription 5a activity
@nl
prefLabel
Nuclear factor kappaB-dependen ...... r of transcription 5a activity
@ast
Nuclear factor kappaB-dependen ...... r of transcription 5a activity
@en
Nuclear factor kappaB-dependen ...... r of transcription 5a activity
@nl
P2093
P2860
P3181
P356
P1476
Nuclear factor kappaB-dependen ...... r of transcription 5a activity
@en
P2093
Bernd Dörken
Christine Hacker
Claus Scheidereit
Harald Stein
Ioannis Anagnostopoulos
Martin Zenke
Petra Lemke
Stephan Mathas
P2860
P304
P3181
P356
10.1084/JEM.20020062
P407
P577
2002-09-01T00:00:00Z